This evaluation will be conducted in ten countries involved in the Catalyzing Pediatric TB Innovation (CaP-TB) project: Cameroon, Cote D'Ivoire, Democratic Republic of Congo, Kenya, Lesotho, Malawi, Tanzania, Uganda, Zimbabwe and India. The CaP-TB project is a project designed to use innovative methods and capacity building to strengthen the health systems of developing countries in terms of pediatric TB case detection, early accurate diagnosis and effective treatment. This project is funded by Unitaid and is implemented by Elizabeth Glaser Pediatric AIDS Foundation. EGPAF proposes to evaluate the implementation of CaP-TB in up to 450 sites in ten participating countries. This evaluation will assess the effects of CaP-TB innovative interventions on selected service delivery outcomes as compared to routine TB program in a sub-set of project sites in the ten countries.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Children Screened for TB
Timeframe: December 2018-September 2021
Children With Presumptive TB
Timeframe: December 2018-September 2021
Children With Presumptive TB Referred for Lab-based TB Diagnosis
Timeframe: December 2018-September 2021
Children With Presumptive TB Tested Using GeneXpert
Timeframe: December 2018-September 2021
Children Initiated on TB Preventive Therapy
Timeframe: December 2018-September 2021
Children Completing TB Preventive Therapy
Timeframe: December 2018-September 2021
Children Diagnosed With Active TB
Timeframe: December 2018-September 2021
Children Initiated on TB Treatment
Timeframe: December 2018-September 2021
Children Achieving Treatment Success
Timeframe: December 2018-September 2021
TB Contacts Successfully Traced
Timeframe: December 2018-September 2021
TB Contacts Screened Negative for TB
Timeframe: December 2018-September 2021
TB Contacts Eligible for Preventive Therapy
Timeframe: December 2018-September 2021